Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Junko Ohashi"'
Autor:
Toshiki Katsura, Junko Ohashi
Publikováno v:
British journal of community nursing. 24(7)
As the world's population ages, efforts to improve quality of life (QOL) in old age are gaining public attention. In this study, a programme was conducted for older people with the aim of clarifying their life goals related to QOL and the meaning of
Autor:
JUNKO OHASHI1 j1211703@ed.tus.ac.jp, SHINJI TSUJIKAWA1 shinji@rs.kagu.tus.ac.jp
Publikováno v:
Thirteenth Marcel Grossmann Meeting, The: on Recent Developments in Theoretical & Experimental General Relativity, Astrophysics & Relativistic Field Theories - Proceedings of the Mg13 Meeting on General Relativity (In 3 Volumes). 2015, p1522-1524. 3p.
Publikováno v:
Journal of Rural Medicine : JRM
Objective: The purpose of this study was to examine the relationship between the emotional intelligence quotient and health-related quality of life using structural equation modeling. Methods: A self-administered questionnaire survey was conducted am
Publikováno v:
The Tohoku Journal of Experimental Medicine. 228:305-315
Many studies have aimed to identify anti-atherogenic agents in cardiovascular medicine. We have recently demonstrated that the combination therapy with olmesartan (OLM), an angiotensin II receptor blocker, and azelnidipine (AZL), a dihydroprydine cal
Publikováno v:
Circulation Journal. 76:1768-1779
Background: Endothelium-derived relaxing factors play an important role in cardiovascular homeostasis. Among them, endothelium-derived hyperpolarizing factor (EDHF) is important especially in microcirculation. It has previously been demonstrated that
Autor:
Satoshi Yasuda, Hirotaka Sawano, Hiroshi Hazui, Isao Ukai, Hiroyuki Yokoyama, Junko Ohashi, Kazuhiro Sase, Akiko Kada, Hiroshi Nonogi, null The J-PULSE Investigators
Publikováno v:
Circulation Journal. 74:2308-2313
Background: Nifekalant hydrochloride (NIF) is an intravenous class-III antiarrhythmic agent that purely blocks the K+-channel without inhibiting β-adrenergic receptors. The present study was designed to investigate the feasibility of NIF as a life-s
Autor:
Junko Ohashi, Yasushi Hoshikawa, Shunsuke Tawara, Yoshihiro Fukumoto, Zhulanqiqige Do.e, Tomohiro Tada, Kenya Saji, Takashi Kondo, Kohichiro Sugimura, Hiroshi Fujita, Aya Takaki, Hiroaki Shimokawa, Jun Nawata, Makoto Nakano
Publikováno v:
Circulation Journal. 73:1731-1739
Background: Direct evidence for Rho-kinase activation in patients with pulmonary hypertension (PH) is still lacking. Methods and Results: Rho-kinase activity in circulating neutrophils was examined by determining the ratio of phosphorylated/total for
Autor:
Toyotaka Yada, Hiroto Yamagishi, Keiko Morikawa, Nobuyuki Yanagihara, Aya Takaki, Junko Ohashi, Hiroaki Shimokawa, Masato Tsutsui, Yoshinori Murayama, Ender Tekes
Publikováno v:
The Journal of Experimental Medicine
The endothelium plays an important role in maintaining vascular homeostasis by synthesizing and releasing several relaxing factors, such as prostacyclin, nitric oxide (NO), and endothelium-derived hyperpolarizing factor (EDHF). We have previously dem
Autor:
Junko Ohashi, Toshiki Katsura
Publikováno v:
Journal of Rural Medicine.
Autor:
Hiroshi Nonogi, Takashi Kurita, Wataru Shimizu, Junko Ohashi, Shunichi Miyazaki, Isao Morii, Satoshi Yasuda, Shiro Kamakura, Atsushi Kawamura
Publikováno v:
Journal of Cardiovascular Pharmacology. 48:274-279
Nifekalant hydrochloride (NIF) is a novel intravenous class-III antiarrhythmic agent with a pirimidinedione structure that purely blocks the K+ channel without inhibiting beta-adrenergic receptors. The authors investigated the efficacy of NIF for ref